Gallic acid triphenylphosphonium derivatives TPP+-C10 and TPP+-C12 inhibit mitochondrial function in Candida albicans exerting antifungal and antibiofilm effects
Related Experiment Video
Updated: Jun 26, 2026

Quantifying the Antifungal Activity of Peptides Against Candida albicans
Published on: January 13, 2023
Victoria Valderrama1, Paula Sánchez1, Macarena Delso1
1Laboratory of Applied Pharmacology for the Development of Anticancer and Antifungal Drugs, Institute for Research in Dental Sciences (ICOD), Faculty of Dentistry, University of Chile, Santiago, 8380544, Chile.
Aims:
To evaluate the antifungal and antibiofilm activity of gallic acid derivatives TPP+-C10 and TPP+-C12 and their effects on mitochondrial function on two Candida albicans reference strains (ATCC 90029 and ATCC 10231).
Methods And Results:
First, we determined minimal inhibitory concentration (MIC) using a microdilution assay. Both compounds exerted antifungal effects, and their MICs ranged from 3.9 to 13 µM, with no statistically significant differences between them (P > 0.05, t-test). These concentrations served as references for following assays. Subsequently, we measured oxygen consumption with a Clark electrode. Our observations revealed that both drugs inhibited oxygen consumption in both strains with TPP+-C12 exerting a more pronounced inhibitory effect. We then employed flow cytometry with TMRE as a probe to assess mitochondrial membrane potential. For each strain assayed, the compounds induced a decay in transmembrane potential by 75%-90% compared to the control condition (P < 0.05, ANOVA). Then, we measured ATP levels using a commercial kit. TPP+-C12 showed a 50% decrease of ATP content (P < 0.05 ANOVA), while TPP+-C10 exhibited a less pronounced effect. Finally, we assessed the antibiofilm effect using the MTT reduction assay. Both compounds were effective, but TPP+-C12 displayed a greater potency, requiring a lower concentration to inhibit 50% of biofilms viability (P < 0.05, t-test).
Conclusions:
Derivatives of gallic acid linked to a TPP+ group exert antifungal and antibiofilm activity through impairment of mitochondrial function in C. albicans.
Insights
Gallic acid derivatives TPP+-C10 and TPP+-C12 show antifungal and antibiofilm properties against Candida albicans. These compounds disrupt mitochondrial function, inhibiting oxygen consumption and ATP production in the fungal cells.
Area of Science:
- Mycology
- Biochemistry
- Antimicrobial Research
Background:
- Candida albicans is a leading cause of opportunistic fungal infections.
- Developing novel antifungal agents with unique mechanisms of action is crucial.
- Gallic acid derivatives offer a promising scaffold for new drug discovery.
Purpose of the Study:
- To evaluate the antifungal and antibiofilm activity of gallic acid derivatives TPP+-C10 and TPP+-C12.
- To investigate the effects of these compounds on Candida albicans mitochondrial function.
- To compare the efficacy of TPP+-C10 and TPP+-C12 against reference strains ATCC 90029 and ATCC 10231.
Main Methods:
- Minimal inhibitory concentration (MIC) determined via microdilution assay.
- Oxygen consumption measured using a Clark electrode.
- Mitochondrial membrane potential assessed by flow cytometry with TMRE.
- ATP levels quantified using a commercial kit.
- Antibiofilm activity evaluated through MTT reduction assay.
Main Results:
- Both TPP+-C10 and TPP+-C12 exhibited significant antifungal activity with MICs between 3.9-13 µM.
- Compounds inhibited oxygen consumption, with TPP+-C12 showing a stronger effect.
- Transmembrane potential decreased by 75%-90% in treated strains.
- TPP+-C12 significantly reduced ATP levels by 50%.
- Both derivatives demonstrated antibiofilm effects, TPP+-C12 being more potent.
Conclusions:
- Gallic acid derivatives TPP+-C10 and TPP+-C12 possess potent antifungal and antibiofilm properties.
- The mechanism of action involves the impairment of mitochondrial function in Candida albicans.
- These compounds represent potential therapeutic agents for candidiasis.
More Related Videos
06:50A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms
Published on: September 16, 2022
09:06Author Spotlight: Photodynamic Therapy as a Novel Approach to Induce Petite Colonies in Drug-Resistant Candida for Antifungal Research
Published on: March 29, 2024
Related Concept Videos
Candidiasis
Antifungal Agents
Antiprotozoal Agents